Clinical Trial of the Inactivated Influenza Vaccine (0.25ml Formulation for Pediatric Use)

PHASE3CompletedINTERVENTIONAL
Enrollment

810

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

May 31, 2009

Study Completion Date

February 28, 2010

Conditions
Influenza
Interventions
BIOLOGICAL

Influenza Split Vaccine

0.25ml, two doses (540 subjects were randomly assigned to receive the first dose, among them, 515 subjects received a boost dose); two doses were assigned to be vaccinated 4 weeks apart

BIOLOGICAL

Inactivated Influenza Vaccine

0.25ml, two doses (270 subjects were randomly assigned to receive the first dose; among them, 263 subjects received a boost dose); two doses was administrated at 4 weeks apart

Trial Locations (1)

223000

Jiangsu Provincial Center for Disease Prevention and Control, Huaian

All Listed Sponsors
lead

Hualan Biological Engineering, Inc.

INDUSTRY